FDG PET/MRI评估直肠癌直肠系膜淋巴结结构:与组织病理学的匹配比较
65例直肠癌患者行FDG PET/MRI检查,将直肠系膜淋巴结结构与组织病理学逐一解剖匹配,比较PET/MRI(代谢+形态学标准)与单独MRI(2016 ESGAR标准)检测恶性淋巴结的效能。共匹配835个淋巴结结构,其中104个恶性(12%)。单独MRI敏感度54%、特异度85%;FDG亲和性敏感度75%、特异度79%;FDG阳性或ESGAR恶性标准联合敏感度76%,FDG阳性且ESGAR恶性标准联合特异度90%。
要点
- FDG PET/MRI联合代谢与形态学标准可降低直肠癌淋巴结分期不足的风险。
- 单独MRI敏感度54%、特异度85%;FDG亲和性敏感度75%、特异度79%。
- FDG阳性且ESGAR恶性标准联合特异度达90%。
核心结论
- 与单独MRI相比,FDG PET/MRI通过降低淋巴结分期不足的风险提供潜在附加价值。
研究设计与样本
- 65例患者(中位年龄70岁,IQR 61-74;39例男性)行FDG PET/MRI检查,并将直肠系膜淋巴结结构与组织病理学进行个体化解剖匹配;以组织病理学为金标准,计算淋巴结水平和患者水平的恶性识别准确率;另评估新辅助治疗后淋巴结再分期的FDG PET/MRI与MRI使用ESGAR标准。
诊断标准与关键数值
- 单独MRI对淋巴结恶性的敏感度54%、特异度85%;FDG亲和性敏感度75%、特异度79%;FDG阳性或ESGAR恶性标准联合敏感度76%;FDG阳性且ESGAR恶性标准联合特异度90%;共匹配835个淋巴结结构,其中104个恶性(12%),59/104(57%)为组织病理学证实的淋巴结转移。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: FDG PET/MRI is a promising imaging modality for nodal staging in rectal cancer; however, its role remains to be defined. We aimed to assess its performance in detecting mesorectal malignant lymph node involvement based on both metabolic and morphological criteria at PET/MRI versus at MRI alone.
MATERIALS & METHODS: Sixty-five patients (median age 70 years, IQR 61-74; 39 men) were examined with FDG PET/MRI followed by individual anatomical matching of mesorectal nodal structures between histopathology and MRI. PET N-stage assessment was evaluated using FDG uptake over background levels, MRI N-stage by the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus criteria and PET/MRI was evaluated using both in combination. Histopathological assessment served as gold standard, and the accuracy of identifying malignancy at both nodal and patient level was calculated. Furthermore, FDG PET/MRI and MRI using ESGAR criteria for nodal restaging after neoadjuvant treatment were also evaluated.
RESULTS: In total, 835 nodal structures were matched, of which 104 were malignant (12%); among these, 59/104 (57%) were histopathologically proven lymph node metastases. MRI alone yielded a sensitivity of 54% and specificity of 85% for nodal malignancy, while the corresponding estimates for FDG-avidity gave a 75% sensitivity and 79% specificity. The different combined FDG PET/MRI criteria for malignancy were evaluated: FDG-positivity or malignancy according to ESGAR criteria resulted in a sensitivity of 76%; while the combination of FDG-positivity and malignancy according to ESGAR criteria achieved a specificity of 90%.
CONCLUSION: Compared to MRI alone, FDG PET/MRI offers potential added value by reducing the risk of nodal understaging.
引用
- Rutegård MK, Båtsman M, Axelsson J, et al. FDG PET/MRI for evaluation of nodal mesorectal structures in rectal cancer: A matched comparison to histopathology. Eur J Radiol. 2026. PMID: 41880681. doi:10.1016/j.ejrad.2026.112810
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。